作者: Takahiro Mukai , Noriko Suganuma , Kenta Soejima , Junichi Sasaki , Fumihiko Yamamoto
DOI: 10.1248/CPB.56.260
关键词:
摘要: Matrix metalloproteinase-2 (MMP-2) is an attractive target for the diagnosis of cancer and atherosclerosis in nuclear imaging. A cyclic decapeptide, cCTTHWGFTLC (cCTT), has been used as mother compound development MMP-2-imaging agents with high potency selectivity. Most radiolabeled derivatives cCTT currently developed vivo studies MMP-2, however, suffer from low accumulation tissues, such tumors. For enhanced stability tissue penetration, we designed a linear beta-tetrapeptide analog, H-beta 3-Phe-beta-Ala-beta 3-Trp-beta 3-His-OH (1), to mimic cCTT. The component beta-amino acids were prepared by reduction N-protected alpha-amino acid methyl esters alcohols, followed conversion into cyanides, subsequent hydrolysis. Compound 1 was obtained these conventional solution method. In MMP-2 inhibition assay, displayed desirably significant inhibition, which comparable These findings suggest that may serve design agents.